Mode
Text Size
Log in / Sign up

Intrahepatic Cholangiocarcinoma

Part of Cancer

Subtypes of Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma 2 Perihilar cholangiocarcinoma 1

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Intrahepatic Cholangiocarcinoma

5 trials tracked for Intrahepatic Cholangiocarcinoma.

5Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4 Other / NA 1
  1. Phase 2 Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma Completed
  2. Phase 2 Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Completed
  3. Phase 2 Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma Completed
  4. Phase 2 Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment Completed
  5. N/A Stereotactic Body Radiotherapy for Liver Tumors Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.